SiBone (SIBN)
(Delayed Data from NSDQ)
$14.57 USD
+0.30 (2.10%)
Updated Apr 26, 2024 04:00 PM ET
After-Market: $14.57 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
D Value A Growth C Momentum B VGM
Si-Bone (SIBN) Price Targets
Average Price Target | Highest Price Target | Lowest Price Target | Upside to Average Price Target |
---|---|---|---|
$25.89 | $32.00 | $20.00 | 81.43% |
Price Target
Based on short-term price targets offered by nine analysts, the average price target for Si-Bone comes to $25.89. The forecasts range from a low of $20.00 to a high of $32.00. The average price target represents an increase of 81.43% from the last closing price of $14.27.
Analyst Price Targets (9 )
Broker Rating
Si-Bone currently has an average brokerage recommendation (ABR) of 1.11 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by nine brokerage firms. The current ABR compares to an ABR of 1.11 a month ago based on nine recommendations.
Of the nine recommendations deriving the current ABR, eight are Strong Buy and one is Buy. Strong Buy and Buy respectively account for 88.89% and 11.11% of all recommendations. A month ago, Strong Buy made up 88.89%, while Buy represented 11.11%.
Broker Rating Breakdown
Brokerage Recommendations
Today | 1 Week Ago | 1 Month Ago | 2 Months Ago | 3 Months Ago | |
---|---|---|---|---|---|
Strong Buy | 8 | 8 | 8 | 7 | 7 |
Buy | 1 | 1 | 1 | 1 | 1 |
Hold | 0 | 0 | 0 | 0 | 0 |
Sell | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 |
ABR | 1.11 | 1.11 | 1.11 | 1.13 | 1.13 |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Analyst Upgrades/Downgrades
Date | Brokerage Firm | Analyst | Previous | Current |
---|---|---|---|---|
4/3/2024 | Needham & Company | David Saxon | Moderate Buy | Moderate Buy |
2/27/2024 | JMP Securities | David L Turkaly | Strong Buy | Strong Buy |
2/27/2024 | Cantor Fitzgerald & Co | Ross Osborn | Strong Buy | Strong Buy |
12/22/2023 | Truist Securities | Samuel E Brodovsky | Strong Buy | Strong Buy |
11/7/2023 | Canaccord Genuity | William J Plovanic | Not Available | Strong Buy |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Average Brokerage Rating
Current ABR | 1.11 |
ABR (Last week) | 1.11 |
# of Recs in ABR | 9 |
Average Target Price | $25.89 |
LT Growth Rate | 10.90% |
Industry | Medical - Instruments |
Industry Rank by ABR | 94 of 252 |
Current Quarter EPS Est: | -0.29 |